Ciprodexis used in adults and children 6 months of age or older to treat certain types of infections caused by certain germs called bacteria.
Dr Reddys Laboratories Ltd on Tuesday announced the launch of a generic version of Ciprodex (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension in the American market, following approval from the US Food and Drug Administration (USFDA).
Ciprodexis used in adults and children 6 months of age or older to treat certain types of infections caused by certain germs called bacteria.
"We are pleased to launch this first-to-market generic product, illustrating our continued commitment to bring affordable generic medicines to market for patients. At the same time, this product demonstrates that we are actively expanding the depth of our portfolio with our first otic suspension dosage form," Marc Kikuchi, Chief Executive Officer of North America Generics, Dr Reddy's said in a release.